Cited by 336Hormonal and reproductive studiesMenopause: Health Impacts and TreatmentsPharmaceutical Practices and Patient Outcomes

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Trends in Androgen Prescribing in the United States, 2001 to 2011

Open access

Baillargeon, Jacques, Urban, Randall J., Ottenbacher, Kenneth J., Pierson, Karen S., Goodwin, James S.·2013·JAMA Internal Medicine

DOI 10.1001/jamainternmed.2013.6895PMC PMC4100547

Open this paper in CoChat — free account

Abstract

Although commercial sales of androgen replacement therapy (ART) have increased substantially in recent years,1,2 to our knowledge, no national population-based studies of this treatment have been reported. In view of the conflicting evidence on the risks and benefits of ART,3-7 understanding androgen prescribing patterns in the United States is important from both a clinical and a public health perspective. We used data from Clinformatics DataMart (CDM), one of the nation's largest commercial health insurance populations, to examine androgen prescribing patterns in the United States over the past decade.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2013.6895

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Adverse Events Associated With Testosterone Replacement in Middle-Aged and Older Men: A Meta-Analysis of Randomized, Placebo-Controlled Trials
Calof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Self-citation
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled Study
Srinivas-Shankar, U., Roberts, S. A., Connolly, M. J., O'Connell, M. D. L., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1251 · Cited by 629
Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Haddad, R. M., Kennedy, C. C., Caples, S. M., Tracz, M. J., Boloña, E. R., Sideras, K., Úraga, M. V., Erwin, P. J., & Montori, V. M. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.1.29 · Cited by 329
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
Bhasin, S., Singh, A. B., Mac, R. P., Carter, B., Lee, M. I., & Cunningham, G. R. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02676.x · Cited by 219

Show all 6 references

Sorted by citations

Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men
Finkle, W. D., Greenland, S., Ridgeway, G. K., Adams, J. L., Frasco, M. A., Cook, M. B., Fraumeni, J. F., & Hoover, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085805 · Cited by 735
“[4,5] While this has raised public health concerns [2,5,7], significant questions remain.”
Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone
Budoff, M. J., Ellenberg, S. S., Lewis, C. E., Mohler, E. R., Wenger, N. K., Bhasin, S., Barrett-Connor, E., Swerdloff, R. S., Stephens-Shields, A., Cauley, J. A., et al. (2017) · JAMA · doi:10.1001/jama.2016.21043 · Cited by 376
Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men
Sharma, R., Oni, O. A., Gupta, K., Chen, G., Sharma, M., Dawn, B., Sharma, R., Parashara, D., Savin, V. J., Ambrose, J. A., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv346 · Cited by 306
Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial
Basaria, S., Harman, S. M., Travison, T. G., Hodis, H., Tsitouras, P., Budoff, M., Pencina, K. M., Vita, J., Dzekov, C., Mazer, N. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.8881 · Cited by 268
Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse
Handelsman, D. J. (2013) · Medical Journal of Australia · doi:10.5694/mja13.10111 · Cited by 253
Testosterone Therapy and Cardiovascular Risk: Advances and Controversies
Morgentaler, A., Miner, M. M., Caliber, M., Guay, A. T., Khera, M., & Traish, A. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.011 · Cited by 213
Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy
Baillargeon, J., Urban, R. J., Kuo, Y., Ottenbacher, K. J., Raji, M. A., Du, F., Lin, Y., & Goodwin, J. S. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014539918 · Cited by 206
Self-citation
Testosterone replacement therapy and cardiovascular risk
Gagliano‐Jucá, T., & Basaria, S. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0211-4 · Cited by 200
Testosterone Lab Testing and Initiation in the United Kingdom and the United States, 2000 to 2011
Layton, J. B., Li, D., Meier, C. R., Sharpless, J. L., Stürmer‎, T., Jick, S. S., & Brookhart, M. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3570 · Cited by 197
Testosterone Rapidly Increases Neural Reactivity to Threat in Healthy Men: A Novel Two-Step Pharmacological Challenge Paradigm
Goetz, S. M. M., Tang, L., Thomason, M. E., Diamond, M. P., Hariri, A. R., & Carré, J. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.016 · Cited by 188
Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency
Cheetham, T. C., An, J., Jacobsen, S. J., Niu, F., Sidney, S., Quesenberry, C. P., & Eeden, S. K. V. D. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9546 · Cited by 173
Erythrocytosis Following Testosterone Therapy
Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.04.001 · Cited by 168
Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk
Michaud, J. E., Billups, K. L., & Partin, A. W. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215597633 · Cited by 143
Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies
Corona, G., Rastrelli, G., Di Pasquale, G., Sforza, A., Mannucci, E., & Maggi, M. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.04.641 · Cited by 138
Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System
Anderson, J. L., May, H. T., LAPPE, D. L., Bair, T. L., Le, V. T., Carlquist, J. F., & Muhlestein, J. B. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.11.063 · Cited by 132
Pharmacology of testosterone replacement therapy preparations
Shoskes, J., Wilson, M. K., & Spinner, M. L. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.07.10 · Cited by 140
Adverse effects of common medications on male fertility
Samplaski, M. K., & Nangia, A. K. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.145 · Cited by 126
Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis
Alexander, G. C., Iyer, G. S., Lucas, E. J., Lin, D. H., & Singh, S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.09.017 · Cited by 120
Testosterone Prescribing in the United States, 2002-2016
Baillargeon, J., Kuo, Y., Westra, J. R., Urban, R. J., & Goodwin, J. S. (2018) · JAMA · doi:10.1001/jama.2018.7999 · Cited by 114
Self-citation
Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use
Coward, R. M., & McBride, J. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.173938 · Cited by 114
Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy
Baillargeon, J., Urban, R. J., Morgentaler, A., Glueck, C. J., Baillargeon, G., Sharma, G., & Kuo, Y.-F. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.05.012 · Cited by 107
Self-citation
Fundamental Concepts Regarding Testosterone Deficiency and Treatment
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.007 · Cited by 109
Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews
Onasanya, O., Iyer, G. S., Lucas, E. J., Lin, D. H., Singh, S., & Alexander, G. C. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30215-7 · Cited by 104
2016 Update on Medical Overuse: A Systematic Review
Morgan, D. J., Dhruva, S. S., Wright, S. M., & Korenstein, D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5381 · Cited by 104
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials
Trost, L. W., & Mulhall, J. P. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.068 · Cited by 98
Androgen Misuse and Abuse
Handelsman, D. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab001 · Cited by 104
Comparative Safety of Testosterone Dosage Forms
Layton, J. B., Meier, C. R., Sharpless, J. L., Stürmer‎, T., Jick, S. S., & Brookhart, M. A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1573 · Cited by 96
Adverse effects of testosterone replacement therapy: an update on the evidence and controversy
Grech, A., Breck, J., & Heidelbaugh, J. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614548680 · Cited by 81
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study
Bhasin, S., Lincoff, A. M., Basaria, S. S., Bauer, D. C., Boden, W. E., Cunningham, G. R., Davey, D. A., Dubcenco, E., Fukumoto, S., Garcia, M., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.11.016 · Cited by 88
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
Loeb, S., Folkvaljon, Y., Damber, J., Alukal, J. P., Lambe, M. P., & Stattin, P. E. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.5304 · Cited by 84
Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility
Patel, A. S., Leong, J. Y., Ramos, L., & Ramasamy, R. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180036 · Cited by 86
Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis
Houghton, D. E., Alsawas, M., Barrioneuvo, P., Tello, M., Farah, W. H., Beuschel, B., Prokop, L. J., Layton, J. B., Murad, M. H., & Moll, S. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.10.023 · Cited by 84
Using a Psychopharmacogenetic Approach To Identify the Pathways Through Which—and the People for Whom—Testosterone Promotes Aggression
Geniole, S. N., Procyshyn, T. L., Marley, N., Ortiz, T. L., Bird, B. M., Marcellus, A. L., Welker, K. M., Bonin, P. L., Goldfarb, B., Watson, N. V., et al. (2019) · Psychological Science · doi:10.1177/0956797619826970 · Cited by 77
Hypogonadism and the risk of rheumatic autoimmune disease
Baillargeon, J., Snih, S. A., Raji, M. A., Urban, R. J., Sharma, G., Sheffield‐Moore, M., López, D. S., Baillargeon, G. M., & Kuo, Y. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3330-x · Cited by 81
Self-citation
Testosterone therapy, thrombosis, thrombophilia, cardiovascular events
Glueck, C. J., & Wang, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.005 · Cited by 79
Injectable testosterone undecanoate for the treatment of hypogonadism
Corona, G., Maseroli, E., & Maggi, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944896 · Cited by 79
Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States
Rao, P., Boulet, S. L., Mehta, A., Hotaling, J. M., Eisenberg, M. L., Honig, S. C., Warner, L., Kissin, D. M., Nangia, A. K., & Ross, L. S. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.10.063 · Cited by 77
Muscular responses to testosterone replacement vary by administration route: a systematic review and meta‐analysis
Skinner, J. W., Otzel, D. M., Bowser, A., Nargi, D., Agarwal, S., Peterson, M. D., Zou, B., Borst, S. E., & Yarrow, J. F. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12291 · Cited by 76
Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male
Jones, S. D., Dukovac, T., Sangkum, P., Yafi, F. A., & Hellstrom, W. J. G. (2015) · Sexual Medicine Reviews · doi:10.1002/smrj.43 · Cited by 76
Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney
Li, C. Y., Basit, A., Gupta, A., Gáborik, Z., Kis, E., & Prasad, B. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.027 · Cited by 73
Testosterone Therapy: What We Have Learned From Trials
Corona, G., Torres, L. O., & Maggi, M. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.11.270 · Cited by 78
American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Testosterone and Cardiovascular Risk
Goodman, N. F., Guay, A. T., Dandona, P., Dhindsa, S., Faiman, C., & Cunningham, G. R. (2015) · Endocrine Practice · doi:10.4158/ep14434.ps · Cited by 72
Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians
Diem, S. J., Greer, N. L., MacDonald, R. H., McKenzie, L. G., Dahm, P., Ercan-Fang, N. G., Estrada, A., Hemmy, L. S., Rosebush, C. E., Fink, H. A., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-0830 · Cited by 72
Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
Pastuszak, A. W., Gomez, L. P., Scovell, J. M., Khera, M., Lamb, D. J., & Lipshultz, L. I. (2015) · Sexual Medicine · doi:10.1002/sm2.76 · Cited by 71
The Bull of Wall Street: Experimental Analysis of Testosterone and Asset Trading
Nadler, A., Jiao, P., Johnson, C. J., Alexander, V., & Zak, P. J. (2017) · Management Science · doi:10.1287/mnsc.2017.2836 · Cited by 65
Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the C ardiovascular H ealth S tudy
Shores, M. M., Arnold, A. M., Biggs, M. L., Longstreth, W. T., Smith, N. L., Kizer, J. R., Cappola, A. R., Hirsch, C. H., Marck, B. T., & Matsumoto, A. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12452 · Cited by 71
Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism
Sharma, R., Oni, O. A., Chen, G., Sharma, M., Dawn, B., Sharma, R., Parashara, D., Savin, V. J., Barua, R. S., & Gupta, K. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.007 · Cited by 68
Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism
Seftel, A. D., Kathrins, M. N., & Niederberger, C. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.06.002 · Cited by 63
Reproductive Hormones and Longitudinal Change in Bone Mineral Density and Incident Fracture Risk in Older Men: The Concord Health and Aging in Men Project
Hsu, B., Cumming, R. G., Seibel, M. J., Naganathan, V., Blyth, F., Bleicher, K., Dave, A., Couteur, D. G. L., Waite, L. M., & Handelsman, D. J. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2493 · Cited by 63
Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men
Borst, S. E., & Yarrow, J. F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2015 · Cited by 63
Decline in opioid prescribing after federal rescheduling of hydrocodone products
Raji, M. A., Kuo, Y., Adhikari, D., Baillargeon, J., & Goodwin, J. S. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4376 · Cited by 61
Self-citation
Screening and Monitoring in Men Prescribed Testosterone Therapy in the U.S., 2001–2010
Baillargeon, J., Urban, R. J., Kuo, Y.-F., Holmes, H. M., Raji, M. A., Morgentaler, A., Howrey, B. T., Lin, Y.-L., & Ottenbacher, K. J. (2015) · Public Health Reports® · doi:10.1177/003335491513000207 · Cited by 61
Self-citation
Infertility in the Aging Male
Mazur, D. J., & Lipshultz, L. I. (2018) · Current Urology Reports · doi:10.1007/s11934-018-0802-3 · Cited by 65
Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic Study
Etminan, M., Skeldon, S., Goldenberg, S. L., Carleton, B., & Brophy, J. M. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1534 · Cited by 59
Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer
Baillargeon, J., Kuo, Y., Fang, X., & Shahinian, V. B. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.05.099 · Cited by 58
Self-citation
Testosterone replacement therapy and hospitalization rates in men with COPD
Baillargeon, J., Urban, R. J., Zhang, W., Zaiden, M. F., Javed, Z., Sheffield‐Moore, M., Kuo, Y., & Sharma, G. (2018) · Chronic Respiratory Disease · doi:10.1177/1479972318793004 · Cited by 56
Self-citation
Testosterone Deficiency: A Review and Comparison of Current Guidelines
Kwong, J. C. C., Krakowsky, Y., & Grober, E. D. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.03.262 · Cited by 58
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
Gencer, B., Bonomi, M., Adorni, M. P., Sirtori, C. R., Mach, F., & Ruscica, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09628-2 · Cited by 58
Testosterone deficiency in adults and corresponding treatment patterns across the globe
Anaissie, J. E., DeLay, K. J., Wang, W., Hatzichristodoulou, G., & Hellstrom, W. J. G. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2016.11.16 · Cited by 57
Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men
Lee, J. A., & Ramasamy, R. (2018) · Translational Andrology and Urology · doi:10.21037/tau.2018.04.11 · Cited by 55
High Rates of Depression and Depressive Symptoms Among Men Referred for Borderline Testosterone Levels
Westley, C. J., AMDUR, R. L., & Irwig, M. S. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12937 · Cited by 54
Genetically predicted testosterone and cardiovascular risk factors in men: a Mendelian randomization analysis in the Guangzhou Biobank Cohort Study
Zhao, J., Jiang, C., Lam, T. H., Liu, B., Cheng, K. K., Xu, L., Au Yeung, S. L., Zhang, W., Leung, G. M., & Schooling, C. M. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt239 · Cited by 53
Preserving fertility in the hypogonadal patient: an update
Lipshultz, L. I., Ramasamy, R., & Armstrong, J. M. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.142772 · Cited by 53
Androgen Physiology, Pharmacology, and Abuse
Handelsman, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00138-4 · Cited by 54
Serum Total Testosterone Concentrations in the US Household Population from the NHANES 2011–2012 Study Population
Vesper, H. W., Wang, Y., Vidal, M., Botelho, J. C., & Caudill, S. P. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.245969 · Cited by 53
Testosterone, aging and survival
Shores, M. M., & Matsumoto, A. M. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000057 · Cited by 52
Ascertainment of Testosterone Prescribing Practices in the VA
Jasuja, G. K., Bhasin, S., Reisman, J. I., Berlowitz, D. R., & Rose, A. J. (2015) · Medical Care · doi:10.1097/mlr.0000000000000398 · Cited by 51
Testosterone Replacement Therapy and Cardiovascular Risk: A Review
Giovanni Corona, G., Rastrelli, G., Maseroli, E., Sforza, A., & Maggi, M. (2015) · The World Journal of Men s Health · doi:10.5534/wjmh.2015.33.3.130 · Cited by 51
Oxidative Stress, Testosterone, and Cognition among Caucasian and Mexican-American Men with and without Alzheimer's Disease
Cunningham, R. L., Singh, M., O’Bryant, S. E., Hall, J. R., & Barber, R. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131994 · Cited by 50
Marketing and Testosterone Treatment in the USA: A Systematic Review
Bandari, J., Ayyash, O. M., Emery, S., Wessel, C. B., & Davies, B. J. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.10.016 · Cited by 51
Testosterone Treatment Is a Potent Tumor Promoter for the Rat Prostate
Bosland, M. C. (2014) · Endocrinology · doi:10.1210/en.2014-1688 · Cited by 47
Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study
Loo, S. Y., Azoulay, L., Nie, R., Dell’Aniello, S., Yu, O. H. Y., & Renoux, C. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.022 · Cited by 48
Is Testosterone Replacement Therapy in Older Men Effective and Safe?
Yabluchanskiy, A., & Tsitouras, P. D. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00716-2 · Cited by 47
Factors Influencing Prostate-Specific Antigen Response among Men Treated with Testosterone Therapy for 6 Months
Morgentaler, A., Benesh, J. A., Denes, B. S., Kan‐Dobrosky, N., Harb, D. E., & Miller, M. G. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12657 · Cited by 46
Exogenous testosterone enhances cortisol and affective responses to social-evaluative stress in dominant men
Knight, E. L., Christian, C. B., Morales, P. J., Harbaugh, W. T., Mayr, U., & Mehta, P. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.08.014 · Cited by 44
An update on male hypogonadism therapy
Surampudi, P. N., Swerdloff, R. S., & Wang, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.913022 · Cited by 46
Evolution of Guidelines for Testosterone Replacement Therapy
Park, H. J., Ahn, S. T., & Moon, D. G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030410 · Cited by 44
Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study
Jasuja, G. K., Bhasin, S., Reisman, J. I., Hanlon, J. T., Miller, D. R., Morreale, A. P., Pogach, L. M., Cunningham, F. E., Park, A., Berlowitz, D. R., et al. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3940-7 · Cited by 44
Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?
López, D. S., Advani, S., Tsilidis, K. K., Wang, R., & Canfield, S. E. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.05.35 · Cited by 44
Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations
Al‐Sharefi, A., & Quinton, R. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.760 · Cited by 44
Patient satisfaction with testosterone replacement therapies: the reasons behind the choices
Kovac, J. R., Rajanahally, S., Smith, R. P., Coward, R. M., Lamb, D. J., & Lipshultz, L. I. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12369 · Cited by 42
Changes in testosterone related to body composition in late midlife: Findings from the 1946 British birth cohort study
Bann, D., Wu, F. C. W., Keevil, B. G., Lashen, H., Adams, J. E., Hardy, R., Terrera, G. M., Kuh, D. J., Ben‐Shlomo, Y., & Ong, K. K. (2015) · Obesity · doi:10.1002/oby.21092 · Cited by 41
Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study
Kaminetsky, J. C., Jaffe, J. S., & Swerdloff, R. S. (2015) · Sexual Medicine · doi:10.1002/sm2.80 · Cited by 43
Testosterone, thrombophilia, thrombosis
Freedman, J., Glueck, C. J., Prince, M., Riaz, R., & Wang, P. (2015) · Translational research · doi:10.1016/j.trsl.2014.12.003 · Cited by 41
The Relationship Between Testosterone-Replacement Therapy and Lower Urinary Tract Symptoms: A Systematic Review
Kathrins, M. N., Doersch, K., Nimeh, T., Canto, A., Niederberger, C., & Seftel, A. D. (2015) · Urology · doi:10.1016/j.urology.2015.11.006 · Cited by 41
Testosterone Replacement Therapy in Hypogonadal Men
Wang, C., & Swerdloff, R. S. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.005 · Cited by 48
Patterns of testosterone prescription overuse
Jasuja, G. K., Bhasin, S., & Rose, A. J. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000336 · Cited by 39
Type 2 Diabetes and Testosterone Therapy
Hackett, G. I. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180027 · Cited by 39
Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014
Zhou, C. K., Advani, S., Chaloux, M., Gibson, J. T., Yu, M., Bradley, M. C., Hoover, R. N., & Cook, M. B. (2020) · The Journal of Urology · doi:10.1097/ju.0000000000000744 · Cited by 38
Translational studies in older men using testosterone to treat sarcopenia.
Urban, R. J., Dillon, E. L., Choudhary, S., Zhao, Y., Horstman, A. M. H., Tilton, R. G., & Sheffield‐Moore, M. (2014) · Europe PMC (PubMed Central) · Cited by 39
Self-citation
Testosterone Replacement Therapy Faces FDA Scrutiny
Garnick, M. B. (2014) · JAMA · doi:10.1001/jama.2014.17334 · Cited by 37
The Relationship Between Testosterone Therapy and Rotator Cuff Tears, Repairs, and Revision Repairs
Testa, E. J., Albright, J. A., Hartnett, D. A., Lemme, N. J., Daniels, A. H., Owens, B. D., & Arcand, M. A. (2023) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-22-00554 · Cited by 36
Testosterone: a hormone preventing cardiovascular disease or a therapy increasing cardiovascular events?
Gencer, B., & Mach, F. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv439 · Cited by 38
Improving clinical outcomes through attention to sex and hormones in research
Mielke, M. M., & Miller, V. M. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00531-z · Cited by 40
Controversies and Advances With Testosterone Therapy: A 40-Year Perspective
Morgentaler, A. (2015) · Urology · doi:10.1016/j.urology.2015.11.034 · Cited by 35
Relation of Testosterone Normalization to Mortality and Myocardial Infarction in Men With Previous Myocardial Infarction
Oni, O. A., Dehkordi, S. H. H., Jazayeri, M., Sharma, R., Sharma, M., Masoomi, R., Sharma, R., Gupta, K., & Barua, R. S. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.019 · Cited by 35
Characterising the safety of clomiphene citrate in male patients through prostate‐specific antigen, haematocrit, and testosterone levels
Chandrapal, J. C., Nielson, S., Patel, D. P., Zhang, C., Presson, A. P., Brant, W. O., Myers, J. B., & Hotaling, J. M. (2016) · BJU International · doi:10.1111/bju.13546 · Cited by 38
The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men
Piszczek, J., Mamdani, M., Antoniou, T., Juurlink, D. N., & Gomes, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098003 · Cited by 34
Hypogonadal symptoms in young men are associated with a serum total testosterone threshold of 400 ng/ dL
Scovell, J. M., Ramasamy, R., Wilken, N., Kovac, J. R., & Lipshultz, L. I. (2014) · British Journal of Urology · doi:10.1111/bju.12970 · Cited by 33
Testosterone Imposters: An Analysis of Popular Online Testosterone Boosting Supplements
Balasubramanian, A., Thirumavalavan, N., Srivatsav, A., Yu, J., Lipshultz, L. I., & Pastuszak, A. W. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.12.008 · Cited by 32

Authors: Baillargeon, J., Urban, R. J., Ottenbacher, K. J., Pierson, K. S., & Goodwin, J. S.
Affiliations: The University of Texas Medical Branch at Galveston (US)
ORCID: Baillargeon, Jacques
Urban, Randall J.
Ottenbacher, Kenneth J.
Goodwin, James S.
Venue: JAMA Internal Medicine
Publisher: American Medical Association (AMA)
Published: 2013-08-12
Volume: 173
Issue: 15
Pages: 1465
ISSN: 2168-6106 (ISSN-L)
DOI: 10.1001/jamainternmed.2013.6895
PMC: PMC4100547
OpenAlex: W1975148982
Cited by: 336
References: 6
Citations by year: 2026: 9 · 2025: 10 · 2024: 16 · 2023: 14 · 2022: 18 · 2021: 18 · 2020: 19 · 2019: 21 · 2018: 26 · 2017: 35 · 2016: 46 · 2015: 49 · 2014: 47 · 2013: 8
FWCI: 39.33
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA Internal Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (UL1TR000071)
National Institute on Aging (5P30AG02482, P30AG024832)
National Cancer Institute (K05CA134923)
National Center for Research Resources (UL1RR029876)
National Center for Advancing Translational Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD065702)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords: testosterone replacement therapy, testosterone, health insurance claims data, commercial health insurance, temporal trends, disease surveillance
MeSH terms: Adult, Androgens, Humans, Male, Middle Aged, Drug Prescriptions, United States, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trends in Androgen Prescribing in the United States, 2001 to 2011

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks